Brief: Cingulate Announces Agreement With Societal Cdmo

Societal CDMO

24/10/2022 23:15

Oct 24 (Reuters) - Cingulate Inc  CING.O :
    * CINGULATE ANNOUNCES AGREEMENT WITH SOCIETAL CDMO AND
PROVIDES
CLINICAL UPDATE
    * CINGULATE INC - CTX-1301 PHASE 3 FIXED-DOSE PEDIATRIC AND
ADOLESCENT SAFETY AND EFFICACY STUDY IS NOW EXPECTED TO COMMENCE
IN MID-2023
    * CINGULATE INC - PREPARING TO INITIATE A PHASE 3 ADULT
DOSE-OPTIMIZATION STUDY LATER THIS YEAR FOR ITS LEAD CANDIDATE,
CTX-1301
    * CINGULATE INC - WE PLAN TO SUBMIT A NEW DRUG APPLICATION
(NDA)
TO FOOD AND DRUG ADMINISTRATION (FDA) IN FIRST HALF OF 2024
    * CINGULATE INC - STUDY IS EXPECTED TO COMMENCE IN DECEMBER
2022

Source text for Eikon:  ID:nGNXc7BVGC 
Further company coverage:  CING.O 
 ((Reuters.Briefs@thomsonreuters.com;))